High-altitude cerebral edema: its own entity or end-stage acute mountain sickness?

REF Turner, H Gatterer, M Falla… - Journal of Applied …, 2021 - journals.physiology.org
High-altitude cerebral edema (HACE) and acute mountain sickness (AMS) are
neuropathologies associated with rapid exposure to hypoxia. However, speculation remains …

High-altitude exposures and intestinal barrier dysfunction

ZJ McKenna, F Gorini Pereira… - American Journal …, 2022 - journals.physiology.org
Gastrointestinal complaints are often reported during ascents to high altitude (> 2,500 m),
though their etiology is not known. One potential explanation is injury to the intestinal barrier …

Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence

CN Schmickl, RL Owens, JE Orr… - BMJ open …, 2020 - bmjopenrespres.bmj.com
Introduction Acetazolamide (AZM) is used for various conditions (eg, altitude sickness, sleep
apnoea, glaucoma), but therapy is often limited by its side effect profile. Our objective was to …

Therapeutic potential and molecular mechanisms of salidroside in ischemic diseases

J Han, L Luo, Y Wang, S Wu, V Kasim - Frontiers in Pharmacology, 2022 - frontiersin.org
Rhodiola is an ancient wild plant that grows in rock areas in high-altitude mountains with a
widespread habitat in Asia, Europe, and America. From empirical belief to research studies …

[HTML][HTML] High-altitude illness: Management approach

G Aksel, ŞK Çorbacıoğlu, C Özen - Turkish Journal of Emergency Medicine, 2019 - Elsevier
In high altitudes, usually above 2500 m, travelers are faced with decreased partial pressure
of oxygen along with decreased barometric pressure. High-altitude illness, a syndrome of …

Interventions for treating acute high altitude illness

D Simancas‐Racines… - Cochrane Database …, 2018 - cochranelibrary.com
Background Acute high altitude illness is defined as a group of cerebral and pulmonary
syndromes that can occur during travel to high altitudes. It is more common above 2500 …

Acetazolamide to prevent adverse altitude effects in COPD and healthy adults

M Furian, M Mademilov, A Buergin… - NEJM …, 2022 - evidence.nejm.org
Background We evaluated the efficacy of acetazolamide in preventing adverse altitude
effects in patients with moderate to severe chronic obstructive pulmonary disease (COPD) …

Carbonic anhydrase inhibition ameliorates inflammation and experimental pulmonary hypertension

H Hudalla, Z Michael, N Christodoulou… - American Journal of …, 2019 - atsjournals.org
Inflammation and vascular smooth muscle cell (VSMC) phenotypic switching are causally
linked to pulmonary arterial hypertension (PAH) pathogenesis. Carbonic anhydrase …

Carbonic anhydrase, obstructive sleep apnea and hypertension: effects of intervention

E Hoff, D Zou, S Schiza, Y Demir, L Grote… - Journal of sleep …, 2020 - Wiley Online Library
Whole blood carbonic anhydrase activity (CAa) is increased in patients with obstructive
sleep apnea (OSA). Our study investigated the influence of positive airway pressure (PAP) …

Effects of acetazolamide combined with remote ischemic preconditioning on risk of acute mountain sickness: a randomized clinical trial

M Liu, X Jiao, R Li, J Li, L Wang, L Wang, Y Wang, C Lv… - BMC medicine, 2024 - Springer
Background We aimed to determine whether and how the combination of acetazolamide
and remote ischemic preconditioning (RIPC) reduced the incidence and severity of acute …